Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PPARγ Agonist Treatment for Cocaine Dependence

NCT02774343 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT02774343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PPARγ Agonist Treatment for Cocaine Dependence
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2012
Completion date
June 30, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, cocaine use disorder